Growth Metrics

Cogent Biosciences (COGT) Other Gross PP&E Adjustments (2017 - 2021)

Cogent Biosciences has reported Other Gross PP&E Adjustments over the past 5 years, most recently at -$3.2 million for Q3 2021.

  • Quarterly results put Other Gross PP&E Adjustments at -$3.2 million for Q3 2021, up 35.61% from a year ago — trailing twelve months through Dec 2021 was -$1.8 million (up 64.89% YoY), and the annual figure for FY2020 was -$5.2 million, down 530.88%.
  • Other Gross PP&E Adjustments for Q3 2021 was -$3.2 million at Cogent Biosciences, up from -$3.7 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for COGT hit a ceiling of $6.7 million in Q4 2018 and a floor of -$6.3 million in Q1 2019.
  • Median Other Gross PP&E Adjustments over the past 5 years was -$3.9 million (2021), compared with a mean of -$2.3 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: crashed 2918.69% in 2019 and later surged 35.61% in 2021.
  • Cogent Biosciences' Other Gross PP&E Adjustments stood at $5.3 million in 2017, then rose by 27.11% to $6.7 million in 2018, then plummeted by 82.05% to $1.2 million in 2019, then crashed by 530.88% to -$5.2 million in 2020, then surged by 37.73% to -$3.2 million in 2021.
  • The last three reported values for Other Gross PP&E Adjustments were -$3.2 million (Q3 2021), -$3.7 million (Q2 2021), and -$4.2 million (Q1 2021) per Business Quant data.